Agents and Actions

, Volume 6, Issue 4, pp 510–515 | Cite as

Correlation of pulmonary structure with pharmacokinetic function

  • J. W. Ryan
  • Una S. Ryan


Pulmonary Structure Pharmacokinetic Function 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. [1]
    E.H. Starling andE.B. Verney,The Secretion of Urine as Studied on the Isolated Kidney, Proc. R. Soc., Lond. [B]97, 321–363 (1925).Google Scholar
  2. [2]
    B. Eiseman, L. Bryant andT. Waltuch,Metabolism of Vasomotor Agents by the Isolated Perfused Lung, J. Thoracic Cardiovasc. Surg.48, 798–806 (1964).Google Scholar
  3. [3]
    R.L. Hodge, R.D. Lowe andJ.R. Vane,Increased Angiotensin Formation in Response to Carotid Occlusion in the Dog, Nature211, 491–493 (1966).PubMedGoogle Scholar
  4. [4]
    S.H. Ferreira andJ.R. Vane,Half-Lives of Peptides and Amines in the Circulation, Nature215, 1237–1240 (1967).PubMedGoogle Scholar
  5. [5]
    S.H. Ferreira andJ.R. Vane,Prostaglandins: Their Disappearance from and Release into the Circulation, Nature216, 868–873 (1967).PubMedGoogle Scholar
  6. [6]
    R.L. Hodge, K.K.F. Ng andJ.R. Vane,Disappearance of Angiotensin from the Circulation of the Dog, Nature215, 138–141 (1967).PubMedGoogle Scholar
  7. [7]
    K.K.F. Ng andJ.R. Vane,Conversion of Angiotensin I to Angiotensin II, Nature216, 762–766 (1967).PubMedGoogle Scholar
  8. [8]
    K.K.F. Ng andJ.R. Vane,Fate of Angiotensin I in the Circulation, Nature218, 144–150 (1968).PubMedGoogle Scholar
  9. [9]
    J.R. Vane,The Release and Fate of Vaso-Active Hormones in the Circulation, Br. J. Pharmac.35, 209–242 (1969).Google Scholar
  10. [10]
    J. Hughes, C.N. Gillis andF.E. Bloom,The Uptake and Disposition of d-Norepinephrine in Perfused Rat Lung, J. Pharmac. exp. Ther.169, 237–248 (1969).Google Scholar
  11. [11]
    J.M. Strum andA.F. Junod,Autoradiographic Demonstration of 5-Hydroxy-Tryptamine-3 H Uptake by Pulmonary Endothelial Cells, J. Cell Biol.54, 456–467 (1972).CrossRefPubMedGoogle Scholar
  12. [12]
    T.E. Nicholas, J.M. Strum, L.S. Angelo andA.F. Junod,Site and Mechanism of Uptake of 3 H-L-Norepinephrine by Isolated Perfused Rat Lungs, Circ. Res.35, 670–680 (1974).PubMedGoogle Scholar
  13. [13]
    J.W. Ryan andU. Smith,Metabolism of Adenosine-5′-Monophosphate during Circulation through the Lungs, Trans Ass. Am. Phys.84, 297–306 (1971).Google Scholar
  14. [14]
    J.W. Ryan, R.S. Niemeyer andD.W. Goodwin,Metabolic Fates of Bradykinin, Angiotensin I, Adenine Nucleotides and Prostaglandins E 1 and F 1 in the Pulmonary Circulation, in:N. Back andF. Sicuteri, Adv. exp. Med. Biol., vol. 21 (Plenum Press, New York 1972), p. 259–266.Google Scholar
  15. [15]
    J.W. Ryan, R.S. Niemeyer andU.S. Ryan,Metabolism of Prostaglandin F in the Pulmonary Circulation, Prostaglandins10, 101–108 (1975).CrossRefPubMedGoogle Scholar
  16. [16]
    J. Hartiala,Testosterone Metabolism in Rabbit Lung in vitro, Steroids Lipids Res.5, 91–95 (1974).PubMedGoogle Scholar
  17. [17]
    G. Giannopoulos,Uptake and Metabolism of Cortisone and Cortisol by the Fetal Rabbit Lung, Steroids23, 845–853 (1974).CrossRefPubMedGoogle Scholar
  18. [18]
    N.S. Wang, R.V. Kotas, M.E. Avery andW.M. Thurlbeck,Accelerated Appearance of Osmiophilic Bodies in Fetal Lungs Following Steroid Injection, J. appl. Physiol.30, 362–365 (1971).PubMedGoogle Scholar
  19. [19]
    T.E. Nicholas andP.A. Kim,The Metabolism of 3 H-Cortisone and 3 H-Cortisol by the Isolated Perfused Rat and Guinea-Pig Lungs, Steroids25, 387–402 (1975).CrossRefPubMedGoogle Scholar
  20. [20]
    J.W. Ryan, J. Roblero andJ.M. Stewart,Inactivation of Bradykinin in the Pulmonary Circulation, Biochem. J.110, 795–797 (1968).PubMedGoogle Scholar
  21. [21]
    J.W. Ryan, J. Roblero andJ.M. Stewart,Inactivation of Bradykinin in Rat Lung, Pharmac. Res. Commun.1, 192 (1969).Google Scholar
  22. [22]
    J.W. Ryan, J. Roblero andJ.M. Stewart,Inactivation of Bradykinin in Rat Lung, in:N. Back, F. Sicuteri andM. Rocha eSilva, Adv. exp. Med. Biol. vol. 8 (Plenum Press, New York 1970), p. 263–271.Google Scholar
  23. [23]
    S.H. Ferreira,A Bradykinin-Potentiating Factor (BPF) Present in the Venom of Bothrops jararaca, Br. J. Pharmac. Chemother.24, 163–169 (1965).Google Scholar
  24. [24]
    S.H. Ferreira, D.C. Bartelt andL.J. Greene,Isolation of Bradykinin-Potentiating Peptides from Bothrops jararaca Venom, Biochemistry9, 2583–2593 (1970).CrossRefPubMedGoogle Scholar
  25. [25]
    Y.S. Bakhle,Converting Enzyme in vitro Its Measurements and Properties, in:I.H. Page andF.M. Bumpus, Handb. exp. Pharmac., vol. 37 (Springer-Verlag, Berlin 1974), p. 41–80.Google Scholar
  26. [26]
    F.E. Dorer, J.R. Kahn, K.E. Lentz, M. Levine andL.T. Skeggs,Purification and Properties of Angiotensin-Converting Enzyme from Hog Lung, Circ. Res.31, 356–366 (1972).PubMedGoogle Scholar
  27. [27]
    F.E. Dorer, J.R. Kahn, K.E. Lentz, M. Levine andL.T. Skeggs,Hydrolysis of Bradykinin by Angiotensin-Converting Enzyme, Circ. Res.34, 824–827 (1974).PubMedGoogle Scholar
  28. [28]
    J.A. Goffinet andP.J. Mulrow,Estimation of Angiotensin Clearance by an in vivo Assay, Clin. Res.11, 408 (1963).Google Scholar
  29. [29]
    J. Roblero, J.W. Ryan andJ.M. Stewart,Assay of Kinins by Their Effects on Blood Pressure, Res. Commun. Chem. Path. Pharmac.6, 207–212 (1973).Google Scholar
  30. [30]
    F.E. Dorer, J.W. Ryan andJ.M. Stewart,Hydrolysis of Bradykinin and Its Higher Homologues by Angiotensin-Converting Enzyme, Biochem. J.141, 915–917 (1974).PubMedGoogle Scholar
  31. [31]
    J.W. Ryan, J.M. Stewart, W.P. Leary andJ.G. Ledingham,Metabolism of Angiotensin I in the Pulmonary Circulation, Biochem. J.120, 221–223 (1970).PubMedGoogle Scholar
  32. [32]
    J.W. Ryan, R.S. Niemeyer, D.W. Goodwin, U. Smith andJ.M. Stewart,Metabolism of (8-l-[14 C]phenylalanine)-Angiotensin I in the Pulmonary Circulation, Biochem. J.125, 921–923 (1971).PubMedGoogle Scholar
  33. [33]
    J.W. Ryan, U. Smith andR.S. Niemeyer,Angiotensin I: Metabolism by Plasma Membrane of Lung, Science176, 64–66 (1972).PubMedGoogle Scholar
  34. [34]
    R.K. Türker, M. Yamamoto, F.M. Bumpus andP.A. Khairallah,Lung Perfusion with Angiotensin I and II. Evidence of Release of Myotropic and Inhibitory Substances, Circ. Res.28, 559–567 (1971).Google Scholar
  35. [35]
    J.W. Ryan andU. Smith,A Rapid, Simple Method for Isolating Pinocytotic Vesicles and Plasma Membrane of Lung, Biochim. biophys. Acta249, 177–180 (1971).PubMedGoogle Scholar
  36. [36]
    U. Smith andJ.W. Ryan,Pinocytotic Vesicles of the Pulmonary Endothelial Cell, Chest59, 12S-15S (1971).PubMedGoogle Scholar
  37. [37]
    U. Smith andJ.W. Ryan,An Electron Microscopic Study of the Vascular Endothelium as a Site for Bradykinin and ATP Inactivation in Rat Lung, in:N. Back, F. Sicuteri andM. Rocha eSilva, Adv. Exp. Med. Biol., vol. 8 (Plenum Press, New York 1970), p. 249–261.Google Scholar
  38. [38]
    J.W. Ryan andU. Smith,The Metabolism of Angiotensin I by Endothelial Cells, in: H. Peters,Protides of the Biological Fluids, vol. 20 (Pergamon Press, Oxford 1973), p. 379–384.Google Scholar
  39. [39]
    U. Smith andJ.W. Ryan,Pulmonary Endothelial Cells and Metabolism of Adenine Nucleotides, Kinins and Angiotensin I, in:N. Back andF. Sicuteri, Adv. exp. Med. Biol., vol. 21 (Plenum Press, New York 1972), p. 267–276.Google Scholar
  40. [40]
    A.T. Chiu, J.W. Ryan, U.S. Ryan andF.E. Dorer,A Sensitive Radiochemical Assay for Angiotensin-Converting Enzyme (Kininase II), Biochem. J.149, 297–300 (1975).PubMedGoogle Scholar
  41. [41]
    M. Weigele, S. de Bernardo, W. Leimgruber, R. Cleeland andE. Grumberg,Fluorescent Labeling of Proteins. A New Methodology, Biochem. biophys. Res. Commun.54, 899–905 (1973).CrossRefPubMedGoogle Scholar
  42. [42]
    J.W. Ryan, U.S. Ryan, D.R. Schultz, C. Whitaker, A. Chung andF.E. Dorer,Subcellular Localization of Pulmonary Angiotensin-Converting Enzyme (Kininase II), Biochem. J.146, 497–499 (1975).PubMedGoogle Scholar
  43. [43]
    J.W. Ryan andU.S. Ryan,Metabolic Activities of Plasma Membrane and Caveolae of Pulmonary Endothelial Cells, in:R. de Haller, Proc. 5th Inter. Davos Symp. onAspects of Lung Metabolism (Academic Press), in press (1975).Google Scholar
  44. [44]
    L.T. Skeggs, J.R. Kahn andN.P. Shumway,Preparation and Function of the Hypertensin-Converting Enzyme, J. exp. Med.103, 295–299 (1956).CrossRefPubMedGoogle Scholar
  45. [45]
    T. Nakajima, G. Oshima, H.S.J. Yeh, R. Igic andE.G. Erdös,Purification of the Angiotensin I Converting Enzyme of the Lung, Biochim. biophys. Acta315, 430–438 (1973).Google Scholar
  46. [46]
    D.W. Cushman andH.S. Cheung,Concentrations of Angiotensin-Converting Enzyme in Tissues of the Rat, Biochim. biophys. Acta250, 261–265 (1971).PubMedGoogle Scholar
  47. [47]
    C.G. Huggins, R.J. Corcoran, J.S. Gordon, H.W. Henry andJ.P. John,Kinetics of the Plasma and Lung Angiotensin I Converting Enzymes, Circ. Res.26/27, suppl. I I-93–I-108 (1970).Google Scholar
  48. [48]
    B.L. Fanburg andJ.B. Glazier,Conversion of Angiotensin I to Angiotensin II in the Isolated Perfused Dog Lung, J. appl. Physiol.35, 325–331 (1973).PubMedGoogle Scholar
  49. [49]
    U. Smith andJ.W. Ryan,Electron Microscopy of Endothelial and Epithelial Components of the Lungs: Correlations of Structure and Function, Fed. Proc.32, 1957–1966 (1973).PubMedGoogle Scholar
  50. [50]
    J.W. Ryan andU.S. Ryan,Biochemical and Morphological Aspects of the Actions and Metabolism of Kinins, in:J.J. Pisano andK.F. Austen, Fogarty Inter. Center Proc., No. 27 (US Government Printing Office, Washington, D.C.), in press (1975).Google Scholar

Copyright information

© Birkhäuser-Verlag 1976

Authors and Affiliations

  • J. W. Ryan
    • 1
  • Una S. Ryan
    • 1
  1. 1.Papanicolaou Cancer Research InstituteMiami

Personalised recommendations